RecruitingPhase 1NCT07090499
Oncology
Squamous cell carcinoma of the esophagus
218
studies recruiting now
as of 7 Sept 2026
1,005
studies registered in total
as of 7 Sept 2026
20
countries with a recruiting site
as of 7 Sept 2026
22 May 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecruitingPhase 1 / Phase 2NCT06780111
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
RecruitingPhase 1 / Phase 2NCT07602842
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
RecruitingPhase 1 / Phase 2NCT07405151
A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 218 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Squamous cell carcinoma of the esophagus study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Squamous cell carcinoma of the esophagus
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (WWOX, RNF6, TGFBR2, DLEC1).
Treatments being studied
2 approved treatments and 60 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Tislelizumab (Tevimbra)Approved: Toripalimab (Loqtorzi)
Phase 3Fluorouracil (5.f.u.)
Phase 3Tiragolumab
Phase 3Nivolumab (Nivolumab bms)
Phase 3Tegafur (Citofur)
Phase 3Cisplatin (Cisplatin)
Phase 3Durvalumab (Imfinzi)
Phase 3Gimeracil (Gimeracil component of teysuno)
Phase 3Atezolizumab (Atezolizumab component of tecentriq hybreza)
+ 52 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).